Cleared Traditional

K052257 - VASCULAR SOLUTIONS TWIN-PASS DUAL ACCESS CATHETER

K052257 is an FDA 510(k) clearance for VASCULAR SOLUTIONS TWIN-PASS DUAL ACCES..., manufactured by Vascular Solutions, Inc.. The device is a Class 2 Cardiovascular device with product code DQY cleared through the Traditional 510(k) pathway after a 97-day FDA review.

K052257 · Vascular Solutions, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2005
Decision
97d
Days
Class 2
Risk

K052257 is an FDA 510(k) clearance for the VASCULAR SOLUTIONS TWIN-PASS DUAL ACCESS CATHETER. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Vascular Solutions, Inc. (Minneapolis, US). The FDA issued a Cleared decision on November 23, 2005 after a review of 97 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Vascular Solutions, Inc. devices

FDA 510(k) Submission Details - K052257

510(k) Number K052257 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 18, 2005
Decision Date November 23, 2005
Days to Decision 97 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
28d faster than avg
Panel avg: 125d · This submission: 97d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQY Device Classification - Class 2, Special Controls

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 754
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K052257.
STERLING OTW PTA BALLOON DILATATION CATHETER, MODEL H74939032-XXXXXX
K053116 · Boston Scientific Corp · Dec 2005
STERLING MONORAIL PTA BALLOON DILATATION CATHETER, MODEL H74939031-XXXXXX
K053118 · Boston Scientific Corp · Dec 2005
VASCULAR SOLUTIONS SKYWAY SUPPORT CATHETER
K052258 · Vascular Solutions, Inc. · Dec 2005
ASAHI TORNUS SUPPORT CATHETER
K051772 · Asahi Intecc Co., Ltd. · Sep 2005
EDWARDS PERIPHERAL DILATION CATHETER
K052149 · Edwards Lifesciences, LLC · Sep 2005
MODIFIED CONCENTRIC RETRIEVER, MODEL 90039
K051838 · Concentric Medical, Inc. · Sep 2005